Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Artesunate
92%
Clinical Trial
85%
Malaria
67%
Amodiaquine
56%
Antimalarial Agent
54%
Infection
52%
Adverse Event
49%
Chagas Disease
46%
Malaria Falciparum
43%
Plasmodium falciparum
43%
Ivermectin
38%
Moxidectin
37%
Dihydroartemisinin
35%
Prevalence
33%
Monotherapy
33%
Artemisinin
31%
Amodiaquine Plus Artesunate
31%
Parasite
30%
Microfilaria (Nematode Larva)
30%
Benznidazole
29%
Randomized Controlled Trial
28%
Schistosomiasis
27%
Combination Therapy
26%
Placebo
25%
Pharmacokinetics
23%
Onchocerciasis
23%
Elimination
22%
HIV
21%
Tablet
21%
Mixed Model
20%
Onchocerca volvulus
20%
Parkinson's Disease
20%
Praziquantel
19%
Piperaquine
19%
Neutropenia
19%
Visceral Leishmaniasis
18%
Mefloquine
18%
Lassa Fever
18%
Arteriosclerosis
18%
Fexinidazole
18%
Amphotericin B
18%
Albendazole
18%
Levodopa-Induced Dyskinesia
18%
Miltefosine
17%
Deethylamodiaquine
13%
Diseases
13%
Tolerability
13%
Parasitemia
13%
Nifurtimox
12%
Epidemiology
12%
Medicine and Dentistry
Parkinson's Disease
86%
Clinical Trial
77%
COVID-19
53%
Infection
52%
Prevalence
42%
Congestive Heart Failure
37%
Diseases
33%
Artificial Intelligence
32%
Cohort Effect
32%
Human Immunodeficiency Virus
31%
Chagas Disease
28%
Schistosomiasis
23%
Gait
22%
Arm
22%
Cohort Analysis
22%
Moxidectin
21%
Placebo
21%
Single Drug Dose
21%
Randomized Controlled Trial
21%
Physical Activity
20%
Onchocerca volvulus
20%
Ivermectin
19%
Public Health
19%
Tuberculosis
19%
Comorbidity
19%
Adverse Event
19%
Systematic Review
18%
Arteriosclerosis
18%
Red Wine
18%
Lifestyle Modification
18%
Benznidazole
18%
Mild Cognitive Impairment
18%
Insulin Dependent Diabetes Mellitus
18%
Metabolomics
18%
Acute Heart Infarction
18%
Myocardial Infarction
18%
Infectious Disease
18%
Meta-Analysis
17%
Onchocerciasis
17%
Degenerative Disease
17%
Malaria
16%
Cognitive Defect
16%
Anthropometry
15%
Exercise
15%
Glucose
14%
Parasitemia
14%
Resistance Training
13%
Early Diagnosis
13%
Praziquantel
13%
Education
13%
Keyphrases
Parkinson's Disease
100%
Luxembourg
60%
COVID-19
51%
Parkinson
31%
Idiopathic Parkinson's Disease
31%
Antimalarial Drugs
29%
Mali
27%
Clinical Trials
25%
Malaria
25%
Artesunate
21%
Artesunate-mefloquine
21%
Neutrophils
20%
Plasmodium Falciparum
20%
Meta-analysis
19%
Mild Cognitive Impairment
18%
Onchocerca Volvulus
18%
Fexinidazole
18%
Therapeutic Efficacy
18%
Clinical Report
18%
Coronavirus Disease (COVID)
18%
Phase II/III
18%
Reporting Guidelines
18%
Levodopa-induced Dyskinesia
18%
In Vitro Susceptibility
18%
Senegal
18%
Uncomplicated Malaria
18%
Artificial Intelligence
18%
Infection Rate
18%
Luxembourgish
17%
Falciparum Malaria
16%
Neutropenia
16%
Individual Patient Data
16%
Artemisinin-based Combination Therapy
15%
Clinical Data
14%
95% Confidence Interval
14%
Risk Factors
14%
Quinine
13%
Monotherapy
13%
Dihydroartemisinin-piperaquine
13%
Malaria Infection
13%
Pregnant Women
13%
Healthy Controls
12%
Gabon
12%
Data Management
12%
Vaccination
12%
Epidemiology
12%
Machine Learning
11%
Polysomnography
11%
Disease Duration
11%
Schistosomiasis
11%